Procurement Summary
Country: USA
Summary: Intent to Sole Source X10 Vials of Floxuridine 500Mg Vials
Deadline: 03 Jun 2026
Posting Date: 21 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 141729009
Document Ref. No.: NOI-CC-OLAO-26-006059
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
This is a Notice of Intent, not a request for proposal. The National Institute of Health, Clinical Center (NIH-CC) intends to negotiate on an other than full and open competition basis with the following vendor: Cardinal Health dba Specialty Pharmaceutical Services (JND Therapeutics).
Acquisition Description:
The purpose of this acquisition is to purchase X10 VIALS of Floxuridine 500MG vials for injections for patient care.
The statutory authority for this sole source requirement is 41 U.S.C. 253(c) (1) as implemented by FAR 6.302-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL. All responsible sources that could provide the required may submit a capability statement that will be considered by email (subject line to reference NOI-CC-OLAO-26-006059) by 12:00 PM eastern standard time on 06/03/2026 to: [email protected].
All responses received by the closing date of this synopsis will be considered by the Government. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
Notice ID: noi-cc-olao-26-006059
Department/Ind. Agency: health and human services, department of
Sub-tier: national institutes of health
Product Service Code: 6505 - drugs and biologicals
NAICS Code: 325412 - Pharmaceutical Preparation Manufacturing
Inactive Dates: jun 18, 2026
Inactive Policy: 15 days after response date
Documents
Tender Notice
Documents.zip